Morjen, M.;                     Moslah, W.;                     Touihri-Baraketi, I.;                     Srairi-Abid, N.;                     Luis, J.;                     Marrakchi, N.;                     Jebali, J.    
        Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor. Toxins 2022, 14, 170.
    https://doi.org/10.3390/toxins14030170
    AMA Style
    
                                Morjen M,                                 Moslah W,                                 Touihri-Baraketi I,                                 Srairi-Abid N,                                 Luis J,                                 Marrakchi N,                                 Jebali J.        
                Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor. Toxins. 2022; 14(3):170.
        https://doi.org/10.3390/toxins14030170
    
    Chicago/Turabian Style
    
                                Morjen, Maram,                                 Wassim Moslah,                                 Imen Touihri-Baraketi,                                 Najet Srairi-Abid,                                 José Luis,                                 Naziha Marrakchi,                                 and Jed Jebali.        
                2022. "Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor" Toxins 14, no. 3: 170.
        https://doi.org/10.3390/toxins14030170
    
    APA Style
    
                                Morjen, M.,                                 Moslah, W.,                                 Touihri-Baraketi, I.,                                 Srairi-Abid, N.,                                 Luis, J.,                                 Marrakchi, N.,                                 & Jebali, J.        
        
        (2022). Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor. Toxins, 14(3), 170.
        https://doi.org/10.3390/toxins14030170